Sjögren Syndrome
📧 Sign up to get email alerts when something new happens for Sjögren Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-27Clinical Trial Update: Pregnancy and Medically Assisted Conception in Rare Diseases
Clinical trial NCT02450396 on pregnancy and medically assisted conception in rare autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]
A early Phase 1 study of RD06-04 in active autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-01-27Clinical Trial Update: Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases [Phase 1]
A Phase 1 pharmacokinetics study of the investigational antibody Ianalumab in Chinese participants with autoimmune diseases has been withdra…
-
CLINICAL_TRIALS withdrawal · 2018-03-07Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) [Phase 2]
A Phase 2 trial evaluating GSK2618960 for primary Sjögren's syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome [Phase 1, Phase 2]
A Novartis-sponsored study evaluating pharmacodynamic effects of VAY736 in patients with Primary Sjögren's Syndrome has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-01-09Clinical Trial Update: Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study [Phase 2]
An open-label Phase II trial evaluating abatacept for inflammatory arthritis in patients with primary or secondary Sjögren's syndrome has be…